Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Monika Lamprecht"'
Autor:
Ingo G.H. Schmidt-Wolf, Michael Pfreundschuh, Gabriele Ihorst, Elke Valk, Kristina Fritsch, Mascha Binder, Agnieszka Korfel, Alexander Röth, Juergen Finke, Heidi Fricker, Gerald Illerhaus, Ulrich Keller, Gertlinde Egerer, Elisabeth Schorb, Robert Möhle, Monika Lamprecht, L. von Baumgarten, Johannes Bloehdorn, Benjamin Kasenda, Roland Schroers
Publikováno v:
Leukemia. 31:2623-2629
To investigate safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (HCT-ASCT) in relapsed/refractory (r/r) primary central nervous system lymphoma (PCNSL), we conducted a single-arm multicentre study for imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc670e7af48dacb20c283eccedfd8688
https://doi.org/10.1038/leu.2017.170
https://doi.org/10.1038/leu.2017.170
Autor:
Hans-Heinrich Wolf, Manfred Binder, Gabriele Ihorst, Johannes Bloehdorn, Martina Deckert, Benjamin Kasenda, Anke Morgner, Johannes Atta, Ulrich Keller, Juergen Finke, Peter Hau, Kristina Fritsch, Alexander Röth, Carsten Hirt, Gerald Illerhaus, Norbert Frickhofen, Löw S, Jens Panse, Ralph Naumann, Heß G, Stephanie Sasse, Uwe M. Martens, Stefan W. Krause, Claudia Hader, Monika Lamprecht, Heidi Fricker, Elisabeth Schorb, Robert Möhle
Publikováno v:
Leukemia
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334
Published by Springer Nature, London
Published by Springer Nature, London
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b788727f36c75ddb2bbdc7cd8e48373
http://europepmc.org/articles/PMC5383936
http://europepmc.org/articles/PMC5383936
Autor:
Michael Pfreundschuh, Matthias Edinger, Stephan Stilgenbauer, Hans-Heinrich Wolf, Jürgen Finke, Alexander Röth, Gerald Illerhaus, Martin Bentz, Elke Valk, Gabriele Ihorst, Louisa von Baumgarten, Benjamin Kasenda, Martina Deckert, Gerlinde Egerer, Peter Hau, Claudia Hader, Monika Lamprecht, Kristina Fritsch, Carsten Hirt, Ulrich Keller, Norbert Frickhofen, Elisabeth Schorb, Robert Möhle, Mascha Binder, Heidi Fricker
Publikováno v:
The Lancet Haematology. 3:e388-e397
Summary Background High-dose methotrexate-based chemotherapy is standard for primary CNS lymphoma, but most patients relapse. High-dose chemotherapy with autologous stem cell transplantation (HCT-ASCT) is supposed to overcome the blood–brain barrie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6e6373a03160fae5b3306413017aa97
https://doi.org/10.1016/s2352-3026(16)30050-3
https://doi.org/10.1016/s2352-3026(16)30050-3
Autor:
Schorb Elisabeth, Monika Lamprecht, Mascha Binder, Roland Schroers, Michael Pfreundschuh, Heidi Fricker, Gerald Illerhaus, Fritsch Kristina, Gabriele Ihorst, Robert Möhle, Louisa von Baumgarten, Elke Valk, Ingo G.H. Schmidt-Wolf, Stephan Stilgenbauer, Ulrich Keller, Alexander Röth, Jürgen Finke, Gerlinde Egerer, Agnieszka Korfel, Benjamin Kasenda, Hans-Heinrich Wolf
Publikováno v:
Blood. 128:781-781
Purpose To investigate safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (HCT-ASCT) in patients with relapsed or refractory primary CNS lymphoma (PCNSL). Patients and methods We conducted a single-arm mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a3c05da023f80004c42ba2b748fe8e
https://doi.org/10.1182/blood.v128.22.781.781
https://doi.org/10.1182/blood.v128.22.781.781
Autor:
Marlies Vogt-Schaden, Ingo G.H. Schmidt-Wolf, Rolf Fimmers, Andreas Engert, Hendrik Pels, Gerlinde Egerer, Axel Glasmacher, Martina Deckert, Holger Schulz, Uwe Schlegel, Gabriele Schackert, Frank Kroschinsky, Udo Bode, Carlo Schaller, Annika Juergens, Christopher Bangard, Monika Lamprecht, Heinz Reichmann, Michael Linnebank, Peter Hau
Publikováno v:
Journal of Neuro-Oncology, Vol. 91, No 3 (2009) pp. 299-305
BACKGROUND: A systemic and intraventricular polychemotherapy regimen (the Bonn protocol) without radiotherapy resulted in durable responses in 75% of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11672bf225b01ac6cab0455d377afc9f
https://archive-ouverte.unige.ch/unige:19607
https://archive-ouverte.unige.ch/unige:19607
Autor:
Jens Panse, Nikolas von Bubnoff, Gabriele Ihorst, Gerlinde Egerer, Benjamin Kasenda, Hans-Heinrich Wolf, Peter Hau, Heidi Fricker, Elisabeth Schorb, Martina Deckert, Norbert Frickhofen, Stefan Balabanov, Robert Möhle, Kristina Fritsch, Martin Bentz, Claudia Hader, Monika Lamprecht, Marco Prinz, Gottfried Dölken, Stephan Stilgenbauer, Jürgen Finke, Gerald Illerhaus, Michael Pfreundschuh, Tobias Birnbaum, Alexander Roeth
Publikováno v:
Blood. 120:302-302
Abstract 302 Background: Primary central nervous system lymphoma (PCNSL) is an aggressive non-Hodgkin′s lymphoma with poor prognosis. Addition of methotrexate (MTX) to whole brain radiotherapy (WBRT) has improved the prognosis of patients (pts) wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af1623372d4e3c493c391fa09436c9e9
https://doi.org/10.1182/blood.v120.21.302.302
https://doi.org/10.1182/blood.v120.21.302.302
Autor:
Katrin Patrij, Rolf Fimmers, Annika Jürgens, Peter Hau, Holger Schulz, Marlies Vogt-Schaden, Gabriele Schackert, Andreas Engert, Monika Lamprecht, Hendrik Pels, Frank Kroschinsky, Christoph Bangard, Carlo Schaller, Martina Deckert, Gertlinde Egerer, Ulrich Herrlinger, Michael Linnebank, Marcel Reiser, Ingo G.H. Schmidt-Wolf, Heinz Reichmann, Luise Wätzel
Publikováno v:
Blood. 112:3602-3602
Background: Data on relapsed central nervous system lymphoma (CNSL) is limited. Therefore, we have evaluated the clinical characteristics and outcome of relapsed CNSL patients at our centers. A central nervous system relapse is a serious complication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::505f08b7427c4b2ac9988657ae10d02f
https://doi.org/10.1182/blood.v112.11.3602.3602
https://doi.org/10.1182/blood.v112.11.3602.3602
Autor:
Peter Hau, Heinz Reichmann, Gertlinde Egerer, Annika Jürgens, Ulrich Herrlinger, Christoph Bangard, Michael Linnebank, Monika Lamprecht, Hendrik Pels, Andreas Engert, Ingo G.H. Schmidt-Wolf, Carlo Schaller, Marlies Vogt-Schaden, Sabine Rogowski, Frank Kroschinsky, Martina Deckert, Axel Glasmacher, Holger Schulz, Uwe Schlegel, Gabriele Schackert, Rolf Fimmers
Publikováno v:
Blood. 112:3600-3600
Objectives: A pilot phase II trial was performed to evaluate response rate, response duration, overall survival, and toxicity in primary central nervous system lymphoma (PCNSL) after systemic and intraventricular chemotherapy with deferred radiothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::552947a1dea7359f27d629ed31a530b0
https://doi.org/10.1182/blood.v112.11.3600.3600
https://doi.org/10.1182/blood.v112.11.3600.3600
Autor:
Ingo G.H. Schmidt-Wolf, Gertlinde Egerer, Rolf Fimmers, Michael Linnebank, Uwe Schlegel, Christoph Bangard, Martina Deckert, Hendrick Pels, Monika Lamprecht, Holger Schulz, Marlies Vogt-Schaden, Frank Kroschinsky, Heinz Reichmann, Axel Glasmacher, Gabriele Schackert, Andreas Engert, Annika Jürgens, Ulrich Bogdahn, Carlo Schaller
Publikováno v:
Blood. 110:4440-4440
Background: A systemic and intraventricular polychemotherapy regimen (“Bonn protocol”) with deferred radiotherapy had resulted in durable responses in 75% of patients < 60 years with primary CNS lymphoma (PCNSL), but had been complicated by a hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd8191585a8cf73827689a8a5d9421d
https://doi.org/10.1182/blood.v110.11.4440.4440
https://doi.org/10.1182/blood.v110.11.4440.4440
Autor:
Hendrik Pels, Uwe Schlegel, Holger Schulz, Ingo G.H. Schmidt-Wolf, Annika Juergens, Frank Kroschinsky, Axel Glasmacher, Gertlinde Egerer, C. Wismeth, Monika Lamprecht
Publikováno v:
Blood. 108:2452-2452
Background: Treatment of primary CNS lymphoma (PCNSL) with a combined systemic and intraventricular chemotherapy (Bonn protocol) has achieved an overall response rate (ORR) of 84% and long term complete remissions in a substantial fraction of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e5421506d3bf1d2edb74ec5d3efe87d
https://doi.org/10.1182/blood.v108.11.2452.2452
https://doi.org/10.1182/blood.v108.11.2452.2452